Tomorrows, a global health technology company that connects patients and physicians with pre-approval treatment options, today announced the launch of its new AI-enhanced Expanded Access (EA) SaaS ...

Quantum BioPharma (NASDAQ: QNTM) has received human ethics review committee (HREC) approval in Australia to begin a Phase 2 clinical trial evaluatin ...

Goodwood Fund and Puccetti Funds Management Inc. (collectively, "Goodwood") announced today that Goodwood has notified COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) that Goodwood intends to ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. securities pursuant and/or traceable to the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any ...

In addition to the MRD oral abstract, additional research highlights include: “We have an exciting, diverse, and sizable slate of oncology results being presented at ASCO this year, where each ...

With a market cap of $20.3 billion, Labcorp Holdings Inc. (LH) is a leading healthcare diagnostics company offering a broad ...

McKesson MCK and Cardinal Health CAH are two of the largest healthcare distribution companies in the United States, playing a ...

Countouriotis is the founder of Avenzo Therapeutics, Inc. since 2022, holding the title of President, Chief Executive & Financial Officer. Current jobs include Chairman at Recludix Pharma, Inc. since ...

TQ Therapeutics GmbH (TQx) has acquired Juno Therapeutics GmbH, a cell therapy company, through a share purchase agreement.